“Comment on ‘Apixaban Vs. Aspirin for Stroke Prevention in People With Subclinical Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack: Subgroup Analysis of the ARTESiA Randomized Controlled Trial’”. 2025. Bleeding, Thrombosis and Vascular Biology 4 (2). https://doi.org/10.4081/btvb.2025.179.